glp-1 receptor agonists are contraindicated in Safety and Tolerability of Glucagon-Like Peptide-1 Agonists: A State-of-the-Art Narrative Review | Drugs GLP-1 receptor agonists in people
Description
This increase in cAMP activates downstream effectors such as protein kinase A (PKA) and exchange protein directly activated by cAMP 2 (Epac2), which modulate various cellular responses [8]

(2018) 20 Suppl 1:2233
The inhibitory effects of peripheral administration of peptide YY(3-36) and glucagon-like peptide-1 on food intake are attenuated by ablation of the vagal-brainstem-hypothalamic pathway

Retrieved from: White, M

Obesity and Bariatric Surgery

[DOI] [PMC free article] [PubMed] [Google Scholar] 3.Kehar M., Ibrahim S.H., Ramirez C.M., Amin S.A., Diamond T., Mohammad S
